Patents by Inventor Lietao Li

Lietao Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Rabies composition comprising PIKA adjuvant
    Patent number: 12097254
    Abstract: The present disclosure provides a rabies composition comprising IPRV and PIKA adjuvant, and the pharmaceutical use thereof. The present disclosure also discloses a method for prophylaxis or therapeutic treatment of rabies virus infection, the method comprises a step of administering the rabies vaccine composition to a host. The rabies composition is more stable and safe, and is able to induce earlier and higher titers of neutralizing antibody.
    Type: Grant
    Filed: March 24, 2021
    Date of Patent: September 24, 2024
    Assignee: Yisheng Biopharma (Singapore) PTE LTD
    Inventors: Lietao Li, Yi Zhang, Fang Liu
  • Rabies Composition Comprising Pika Adjuvant
    Publication number: 20220040289
    Abstract: The present disclosure provides a rabies composition comprising IPRV and PIKA adjuvant, and the pharmaceutical use thereof. The present disclosure also discloses a method for prophylaxis or therapeutic treatment of rabies virus infection, the method comprises a step of administering the rabies vaccine composition to a host. The rabies composition is more stable and safe, and is able to induce earlier and higher titers of neutralizing antibody.
    Type: Application
    Filed: March 24, 2021
    Publication date: February 10, 2022
    Inventors: Lietao Li, Yi Zhang, Fang Liu
  • A Rabies Composition Comprising Pika Adjuvant
    Publication number: 20170340727
    Abstract: The present disclosure provides a rabies composition comprising IPRV and PIKA adjuvant, and the pharmaceutical use thereof. The present disclosure also discloses a method for prophylaxis or therapeutic treatment of rabies virus infection, the method comprises a step of administering the rabies vaccine composition to a host. The rabies composition is more stable and safe, and is able to induce earlier and higher titers of neutralizing antibody.
    Type: Application
    Filed: December 23, 2014
    Publication date: November 30, 2017
    Inventors: Lietao Li, Yi Zhang, Fang Liu